Ruxolitinib Intermediates: Essential Components in API Manufacturing
The pharmaceutical industry relies on high-purity chemical intermediates to manufacture active pharmaceutical ingredients (APIs) effectively. One such vital compound is Ruxolitinib, a JAK1/JAK2 inhibitor used in the treatment of myelofibrosis, polycythemia vera, and other chronic inflammatory conditions. The efficiency and quality of Ruxolitinib intermediates directly affect the safety, performance, and regulatory compliance of the final […]
Continue Reading